About Vice-Principal ResearchNews
Compass North participant Fictionary lands investment opportunity
Dec 07, 2022
Kristina Stanley is the founder of Fictionary, a technology company that develops software which helps writers visualize their story arc by analyzing key story elements with AI and gauging how their manuscript compares to fundamental storytelling.
December 6, 2022: U.S. Patent No. 11,522,510 "High-Output Current Transconductance Amplifier"
Dec 06, 2022
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,522,510
Tradvo is changing how people do business online
Dec 06, 2022
Founded by two former »Ê¹ÚÌåÓý’s PhD students, Tradvo is poised to go big helping small businesses flourish online, thanks in no small part to its support from »Ê¹ÚÌåÓý’s Partnerships and Innovation.
Kingston-Syracuse Pathway revives partnership and cross-border collaborations
Nov 30, 2022
Renewed Kingston-Syracuse Pathway collaboration will help facilitate market entry into the U.S. or Canada through soft-landings initiative.
November 29, 2022: U.S. Patent No. 11,512,207 "Anti-smudge and Anti-graffiti Compositions"
Nov 29, 2022
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,512,207
Industry, Academia and Investment
Nov 24, 2022
Most recently, »Ê¹ÚÌåÓý’s took part in the first-ever Hub350 Annual Partner Summit in Kanata, which brought together industry, financial and academic partners to celebrate and strengthen existing collaborations and build new connections
November 15, 2022: U.S. Patent No. 11,498,853 "Water with Switchable Ionic Strength"
Nov 15, 2022
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,498,853
Wings graduate Nephron.Health looking to help kidney disease patients
Nov 15, 2022
For Nephron.Health, the business is more than just a passion project – the team is living the experiences themselves.
mDETECT getting ready to commercialize important cancer detection method
Nov 10, 2022
A »Ê¹ÚÌåÓý’s research discovery has the potential to become a game-changer for breast cancer diagnosis and treatment.
November 8, 2022: U.S. Patent No. 11,492,366 "Platinum Compounds for Binding Guanine Quadruplexes"
Nov 08, 2022
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,492,366Â
»Ê¹ÚÌåÓý’s Professor Stephen Archer's technology has multiple treatment applications
Nov 08, 2022
Professor Stephen Archer and his colleagues, Dr. Danchen Wu and Dr. Michael Wells, have developed an enzyme inhibitor and early research suggests that it may be very effective in fighting cancer, Alzheimer’s disease, pulmonary hypertension.
Using »Ê¹ÚÌåÓý's-developed technology, the future looks bright for QSBRI
Nov 07, 2022
QSBRI's journey demonstrates the long-lasting, social, economic, and international impact of »Ê¹ÚÌåÓý’s research and collaborations with industry.